National Philanthropic Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.25M Sell
13,588
-5,068
-27% -$1.88M 0.08% 99
2026
Q1
$5.46M Sell
18,656
-165
-0.9% -$54.2K 0.06% 93
2025
Q4
$6.6M Sell
18,821
-4,169
-18% -$1.41M 0.07% 88
2025
Q3
$7.43M Buy
22,990
+6,216
+37% +$1.93M 0.08% 70
2025
Q2
$6.52M Sell
16,774
-143
-0.8% -$57.5K 0.09% 74
2025
Q1
$7.36M Sell
16,917
-7,842
-32% -$3.15M 0.12% 62
2024
Q4
$9.13M Buy
24,759
+3,265
+15% +$1.37M 0.13% 58
2024
Q3
$11.2M Sell
21,494
-68
-0.3% -$36.3K 0.2% 47
2024
Q2
$11.7M Sell
21,562
-127
-0.6% -$67.1K 0.22% 45
2024
Q1
$11.2M Sell
21,689
-9
-0% -$4.48K 0.25% 48
2023
Q4
$10.2M Buy
+21,698
New +$10M 0.27% 48

Other funds holding ELV

National Philanthropic Trust's ELV Position: Q2 2026 in Review

National Philanthropic Trust reduced its Elevance Health (ELV) stake by 27% in Q2 2026, selling an estimated $1.88M and leaving 13,588 shares worth $5.25M. The position accounts for 0.08% of the portfolio, ranked #99.

National Philanthropic Trust first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.7M in Q2 2024. 1,513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • National Philanthropic Trust held 13,588 shares of Elevance Health worth $5.25M as of Q2 2026.
  • National Philanthropic Trust sold 5,068 Elevance Health shares in Q2 2026, an estimated $1.88M.
  • Elevance Health made up 0.08% of National Philanthropic Trust's portfolio in Q2 2026, its #99 holding.
  • National Philanthropic Trust first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • National Philanthropic Trust's Elevance Health position peaked at $11.7M in Q2 2024.
  • 1,513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on National Philanthropic Trust's 13F filing for Q2 2026, filed 14 Aug 2026.